CAS: 1217439-06-9 - N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-6-quinolinamine
Fórmula:C13H14N4
InChI:InChI=1S/C13H14N4/c1-9-10-3-2-6-14-12(10)5-4-11(9)17-13-15-7-8-16-13/h2-6H,7-8H2,1H3,(H2,15,16,17)
Clave InChI:InChIKey=FCRZSJQZPZTROM-UHFFFAOYSA-N
SMILES:N=1C=CC=C2C1C=CC(NC3=NCCN3)=C2C
- Sinónimos:
- N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-6-quinolinamine
- 6-Quinolinamine, N-(4,5-dihydro-1H-imidazol-2-yl)-5-methyl-
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Bempedoic Acid Impurity 5 REF: 4Z-B-168009CAS: 1217439-06-9 | - - - | A consultar | Lun 02 Dic 24 | |
Brimonidine Tartrate Impurity 3 REF: 4Z-B-168CAS: 1217439-06-9 | - - - | A consultar | Mar 10 Dic 24 | |
Bempedoic Acid Impurity 10 REF: 4Z-B-168015CAS: 1217439-06-9 | - - - | A consultar | Mar 10 Dic 24 | |
N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-6-quinolinamine REF: 3D-SYB43906CAS: 1217439-06-9 | Min. 95% | - - - | Producto descatalogado |
Ref: 4Z-B-168009
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 2 de Diciembre de 2024
Ref: 4Z-B-168
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Ref: 4Z-B-168015
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-6-quinolinamine
CAS:1217439-06-9
Please enquire for more information about N-(4,5-Dihydro-1H-imidazol-2-yl)-5-methyl-6-quinolinamine including the price, delivery time and more detailed …
Fórmula:
C13H14N4
Pureza:
Min. 95%
Peso molecular:
226.28 g/mol
Ref: 3D-SYB43906
10mg | Descatalogado | Solicitar información | |
25mg | Descatalogado | Solicitar información | |
50mg | Descatalogado | Solicitar información | |
100mg | Descatalogado | Solicitar información | |
250mg | Descatalogado | Solicitar información |